Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > How confident are we in this SP holding?
View:
Post by McBullish on Oct 22, 2024 9:08am

How confident are we in this SP holding?

I've only recently (past 6 months) become aware of Theralase. Im currently sitting right over 100K shares and definitely will be buying more because I think this company is going to change cancer treatment and become very valuable.

I'm just wondering in the absence of news, do we think the SP price will hold or slide back until we get some more news?

I know Im kind of asking for a crystal ball prediction here, but I'm interested in the general consensus from the real longs here about timing to jump in and aquire more shares!

TIA!
Comment by TimboBaggins on Oct 22, 2024 9:26am
Assume it's going way down as always and be surprised when it doesn't. That's how we roll. 
Comment by McBullish on Oct 22, 2024 9:55am
Thanks for the quick response. Looking at the the line chart over the past 5 years would suggest it but I we are much closer to the finish line now with considerable momentum. I buy and hold so it really makes no difference in the end. 
Comment by Infinity on Oct 22, 2024 10:15am
penny flippers are active today.  I am simply waiting for the next Catalyst that is BTD which is around the corner.  
Comment by DeathXray33 on Oct 23, 2024 1:50pm
I'm a buyer @ $5. @ 1.58 million now.
Comment by TommyNickels on Oct 23, 2024 2:06pm
Decent discount now if you think news is coming.
Comment by DeathXray33 on Oct 24, 2024 7:07am
"Rutherrin has been proven preclinically to be activated by Metformin, a common diabetes drug, without the use of light and/or radiation. Even more interesting is that because Rutherrin and Metformin are both scientifically proven to cross the blood-brain barrier, as well as tumour-specific blood barriers, this new discovery potentially allows the precise targeting of cancer cells by ...more  
Comment by TommyNickels on Oct 24, 2024 7:26am
A JV with Big Pharma would do wonders for Theralase !
Comment by DeathXray33 on Oct 24, 2024 3:04pm
"What is Marburg virus? Marburg is a virus from the same family as Ebola. It causes a haemorrhagic fever and has an average fatality rate of 50%, according to the WHO, although rates have been as high as 88% in previous outbreaks." ------------------------------------------------------------"Is there a vaccine? There are no approved vaccines or treatments for Marburg"
Comment by TommyNickels on Oct 24, 2024 3:07pm
A grant from the Govt Canada could help with this.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250